Home Page ::: Anti-Cancer Agents in Medicinal Chemistry

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)


Volume 15, 10 Issues, 2015


Download PDF Flyer




Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 22nd of 58 in

    Chemistry, Medicinal

  • 85th of 202 in

    Oncology


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Michelle Prudhomme


Universite Blaise Pascal - C.N.R.S
Aubiere Cedex
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.939
5 - Year: 3.37

Highlighted Articles

Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014 :14(10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz
DOI: 10.2174/1871520614666140624110458

Rights and Permissions

View Abstract Purchase Online

Endorsement(s)

"All chemists and scientists will welcome Anti-Cancer Agents in Medicinal Chemistry as a fresh and vital source of information for this important field. The journal is highly recommended for essential reading."

Terrence C. Jenkins
YCR Laboratory of Drug Design, UK

Forthcoming Special Issue(s)

Unveiling the mystery of drug combinations for clinical cancer therapy, transforming from empirical into science discipline


Guest Editor(s): Da-Yong Lu
Tentative Publication Date: May, 2016
Submit Abstract via Email Download Description
Special Issue(s) - In-Press

Survival Signaling Through Focal Adhesion Kinase in Tumors


Guest Editor(s): Vita Golubovskaya
Download Description
Authors' Comments
I am glad to have my work published in Anti- Cancer Agents in Cancer. I found the publication process to be professional and efficient. The papers are reviewed rapidly and included promptly to Pubmed.
I highly recommend scientists to submit their papers at Bentham Science Publishers.

Dr. Juan Rafael Orozco Arroyave
Has contributed: FAK and Nanog Cross Talk with p53 in Cancer Stem Cells

Anti-Cancer Agents in Medicinal Chemistry

,

Volume 15

-

Number 3



The Cytotoxic and Mechanistic Effects of Aaptamine on Hepatocellular Carcinoma

; Pp: 291 - 297

Qiao-lu Li, Ping-ping Zhang, Pei-qin Wang, Hao-bing Yu, Fan Sun, Wen-zheng Hu, Wen-hui Wu, Xin Zhang, Fei Chen, Zhi-yong Chu, Jun-ping Zhang, Shun-shen Chen and Hou-wen Lin


DOI: 10.2174/1871520614666141114201027


Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?

; Pp: 307 - 313

Sara Pilotto, Stefania Kinspergher, Umberto Peretti, Anna Calio, Luisa Carbognin, Roberto Ferrara, Matteo Brunelli, Marco Chilosi, Giampaolo Tortora and Emilio Bria


DOI: 10.2174/1871520614666141110170259
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Current Molecularly Targeting Therapies in NSCLC and Melanoma


Supriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, Hiroko Furo, Agnes Kulesza, Leo Lin, Bonnie Sheu, Mark Frakes, Marko Ivanovich and Neelu Puri


View Abstract Purchase Online

  
  


Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics


Richard T. Arkwright, Rahul Deshmukh, Nikhil Adapa, Ryan Stevens, Emily Zonder, Zhongyu Zhang, Pershang Farshi, Reda Saber Ibrahim Ahmed, Hossny Awad El-Banna, Tak-Hang Chan and Q. Ping Dou


View Abstract Purchase Online

  
  


Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines


Zongyuan Yang, Xiaoshui Zhou, Yi Liu, Cheng Gong, Xiao Wei, Taoran Zhang, Ding Ma and Qinglei Gao


View Abstract Purchase Online

  
  


Differential Binding Preference of Methylpheophorbide a and Its Diboronated Derivatives to Albumin and Low Density Lipoproteins


Galina V. Golovina, Georgy N. Rychkov, Valentina A. Ol'shevskaya, Andrei V. Zaitsev, Valery N. Kalinin, Vladimir A. Kuzmin and Alexander A. Shtil


View Abstract Purchase Online

  
  


Anti-Resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients


Farzad Borumandi, Tara Aghaloo, Luke Cascarini, Alexander Gaggl and Kunmi Fasanmade


View Abstract

  
  


4,6-diaryl pyrimidones as constrained chalcone analogues : Design, Synthesis and Evaluation as antiproliferative agents


Dinesh Kumar, Kunal Nepali, P M S Bedi, Suresh Kumar, Fayaz Malik and Subheet Jain


View Abstract

  
  


Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways


Syed Nasir Abbas Bukhari, Ibrahim Jantan and Mohamed Ali Seyed


View Abstract

  
  


A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness


G K Chimal-Ramírez, Na A Espinoza-Sánchez and E M Fuentes-Pananá


View Abstract

  
  


Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective


Harun M. Patel, Rajesh Rane, Neeta Thapliyal, Mahesh Palkar, Mahamadhanif Shaikh and Rajshekhar Karpoormath


View Abstract

  
  


Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap-Dependent


Jiaoyan Han, Jiao Song, Xiangyun Li, Ming Zhu, Wei Guo, Wei Xing, Rongshen Zhao, Xiao He, Xiaoping Liu, Shali Wang, Yunyun Li, Hong Huang and Xiang Xu


View Abstract

  
  


RUNX2 and Osteosarcoma


Na Li, Dongwei Luo, Xiaoxia Hu, Wei Luo, Guanghua Lei, Qian Wang, Ting Zhu, Junxia Gu, Yaojuan Lu and Qiping Zheng


View Abstract

  
  


Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?

, 2015; 15(3): 307 - 313

Sara Pilotto, Stefania Kinspergher, Umberto Peretti, Anna Calio, Luisa Carbognin, Roberto Ferrara, Matteo Brunelli, Marco Chilosi, Giampaolo Tortora and Emilio Bria


DOI: 10.2174/1871520614666141110170259
View Abstract Purchase Online Rights and Permissions

  
  


Berberine Interfered with Breast Cancer Cells Metabolism, Balancing Energy Homeostasis

, 2015; 15(1): 66 - 78

Wen Tan, Ning Li, Rui Tan, Zhangfeng Zhong, Zhanwei Suo, Xian Yang, Yitao Wang and Xiaodong Hu


DOI: 10.2174/1871520614666140910120518
View Abstract Download Free Rights and Permissions

  
  


New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin

, 2014; 14(9): 1228 - 1236

Pascale Moreau, Lyubov G. Dezhenkova, Fabrice Anizon, Lionel Nauton, Vincent Thery, Shuguang Liang, Dmitry N. Kaluzhny and Alexander A. Shtil


DOI: 10.2174/1871520614666140825124456
View Abstract Purchase Online Rights and Permissions

  
  


Advertisement


Related eBooks




Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science